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could be obtained within 30 min using
only 20 lL serum or tryptase calibrators
and showed excellent conformity to the
commercial tryptase assay.
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Background: Allergy induced by grass pol-
len can be reduced by means of sublingual
allergen-specific immunotherapy (IT). One
of the major allergens in grass pollen is
grass Group 1. Two antibody-based meth-
ods, a sandwich-ELISA and an inhibition
ELISA, were developed for the quantifica-
tion of grass Group 1 in grass pollen
extracts. Both methods were compared in
order to determine the most appropriate
assay for use of quantification of Group 1
in a grass pollen IT product that consists
of four different grass pollen extracts.
Method: The sandwich ELISA uses two
specific monoclonal antibodies (7E7 and
1B8) against Lol p1 major allergen, one on
the solid phase and one as detecting anti-
body. The inhibition ELISA (iELISA) uses
one specific monoclonal antibody (7E7)
that is mixed with grass pollen extract and
recombinant Phleum p1 allergen on the
solid phase. The products tested were pol-
len extracts of four different grass species,
i.e. Phleum pratense, Lolium perenne, Poa
pratensis and Secale cereale. The standards
used are well characterised grass Group 1
allergens (Phl p1, Lol p1, Poa p1 and Sec
c1) purified from grass pollen extracts.
Results: The sandwich ELISA showed dif-
ferent curves (e.g. non-parallel lines, differ-
ent OD maxima) when grass pollen
extracts from different grass species were
analysed, while the iELISA showed similar
curves for all four grass species. Further
development of the sandwich-ELISA
would involve separate development of 4
methods with different conditions, while
only one method could be used with the
iELISA for these extracts of 4 grass spe-
cies. Therefore, the iELISA was chosen for
further development and qualification.
Qualification showed that the iELISA gen-
erates reproducible results with low varia-
tion.
Conclusion: Quantification of grass Group
1 major allergen in four different grass spe-
cies can be done with one method using an
iELISA. The sandwich ELISA was less
suitable since different test conditions were
needed when testing different grass species.
The newly developed iELISA can precisely
quantify Group 1 allergen in pollen
extracts from Phleum pratense, Lolium per-
enne, Poa pratensis and Secale cereale.
769
Sensitisation to Act d 2 in patients
allergic to Alternaria alternata: an
epiphenomenon without clinical
significance?
Sanchez-Lopez, J1; Pascal, M2; Gomez-Casado, C3;
Mu~noz-Cano, R1; Rueda, M1; Vilella, R2; Valero, A1;
Dıaz-Perales, A3; Bartra, J1
1Pulmonology and Respiratory Allergy, Hospital Clinic,
Barcelona, Spain; 2Hospital Clinic, Immunology,
Barcelona, Spain; 3Centro de Biotecnologia y Genomica
de Plantas UPM-INIA, Campus de Montegancedo,
Pozuelo de Alarcon, Spain
Background: In the last few years, the
introduction of microarrays in the diagno-
sis of type I allergy is allowing the clini-
cians to have a much more accurate
picture of their allergenic profile. However,
the simultaneous measurement of specific
IgE to multiple molecules can show unex-
pected sensitisations, without knowing
their clinical relevance. For instance, we
have been observing a high prevalence
(74%) of sensitisation to Act d 2 (the
thaumatin of kiwifruit) in patients sensi-
tised to Alt a 1 (major allergen of Alterna-
ria alternata) with a confirmed allergy to
this mould. The aim of the present study
was to clarify if there was any clinical rele-
vance in this finding.
Method: We selected patients allergic to A.
alternata (rhinitis and/or asthma) with a
positive specific IgE (sIgE) to Alt a 1 and
Act d 2 in the allergen microarray immu-
noassay (ImmunoCAP ISAC, ThermoFish-
er Scientific).
Skin prick tests (SPT) were performed
with the commercial available A. alternat-
a and kiwifruit extracts (Laboratorios
LETI), a purified nAct d 2 protein and a
prick by prick with fresh kiwifruit. Total
IgE and sIgE (UniCAP, ThermoFisher
Scientific) to kiwifruit and A. alternata
were obtained, and an open oral food
challenge (OFC) with kiwifruit was also
carried out.
Results: Eighteen patients were selected,
nine of them were skin prick tested and
orally challenged. 9 men, 9 women, median
total IgE 195 kU/l (intercuartile range
(IQR) 128–542). sIgE to kiwi was negative
in all cases, median sIgE to A. alternata
was 9.86 kU/l (IQR 5.5–16.8), median sIgE
to Act d 2 was 1.9 ISU (0.9–4.6), and sIgE
to Alt a 1 was 9.8 ISU (2.5–20.4). A corre-
lation was found between sIgE to Act d 2
and sIgE to Alt a 1 (Rho Spear-
man = 0.686; significance = 0.01).
SPT to A. alternata extract was positive
in all cases, SPT to commercial kiwi, prick
by prick with fresh fruit and nAct d 2 were
all negative. OFC with kiwifruit was well
tolerated in all patients.
Conclusion: In our population, sensitisat-
ion to Act d 2 in the context of an allergy
to A. alternata has no clinical relevance.
This sensitisation could only be seen with
the microarray immunoassay, SPTs and
sIgE to kiwi failed to detect it.
A significant correlation was found
between sIgE to Act d 2 and Alt a 1. Fur-
ther studies are needed to confirm if this
sensitisation is real and in second place, to
figure out if there could be any other link
between both allergens rather than the clin-
ical one.
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Background: The use of purified allergens
as a diagnostic for skin prick test allows
the identification of real sensitisation to a
specific allergen present in a protein extract
and it is a very useful tool for the study of
cross-reactivity. However, the quality of
these products has to be demonstrated. In
that sense, there is no studies about the
stability of purified proteins as reagents for
diagnosis. The objective of the study was
to determine the stability of purified nsLTP
prick tests under different storage condi-
tions.
Method: Pru p 3 and Cor a 8 were purified
in an €AKTAexplorer FPLC and used to
prepare prick tests with a concentration of
30 lg/ml of total LTP. A mixture of puri-
fied LTPs (15 lg/ml of Pru p 3 and 15 lg/
ml of Cor a 8) was selected in order to
increase the diagnosis efficacy. After for-
mulation, pricks were stored at three tem-
peratures (room temperature, 4° and
20°C) and they were analysed monthly
by SDS-PAGE and immunoblot. Pru p 3
or Cor a 8 polyclonal rabbit antibodies
were used in immunoblot experiments.
Finally, pH and glycerol valuation was
also carried out.
Results: SDS-PAGE and immunoblot
results showed that there were not impor-
tant differences in protein molecular
weights or protein band intensity between
the 3 temperatures and during the whole
period of study (6 months). Immunoblot
results showed a slight decrease in the
intensity of Cor a 8 recognition after
6 months. Regarding pH and glycerol val-
ues, both parameters were maintained in
the range of 7.5–8.5 and 45–55%, respec-
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